具有pH-响应性的聚天冬氨酸类载药胶束的制备和释放能力研究

通过大分子引发剂ω-氨基-α-甲氧基聚乙二醇引发N-羧基-α-氨基环内酸酐开环聚合和水合肼侧基改性,制备了一系列聚乙二醇-聚氨基酸类三嵌段共聚物.其中聚氨基酸链段包括具有酰肼基的聚天冬氨酸衍生物(PAHy),以及疏水性的聚丙氨酸链段.引入具有pH响应性的腙键键合阿霉素,利用键合阿霉素与游离阿霉素之间的π-π叠合作用,在聚合物自组装形成胶束过程中通过化学键合+物理包埋的方式充分负载药物.该胶束以聚丙氨酸链段为核心,以PEG链段为冠层,以PAHy链段为包裹药物的壳层.载药胶束的粒径在170 nm左右.研究不同pH值条件下载药胶束的药物释放能力,随环境pH值的降低药物的释放速率显著增加.     

聚乙二醇-聚谷氨酸-聚丙氨酸三嵌段共聚物的合成及其胶束的pH-响应性药物控制释放

通过大分子引发剂ω-胺基-α-甲氧基聚乙二醇引发N-羧基-α-氨基环内酸酐开环聚合和酸性水解制备了一种具有pH-响应性的三嵌段共聚物聚乙二醇-聚谷氨酸-聚丙氨酸(mPEG-PLGA-PLAA).通过核磁共振、ζ-电势、动态光散射、电子显微镜等手段表征了此类三嵌段共聚物的自组装过程及所形成胶束的pH-响应性.使用圆二色谱和红外光谱,分析了胶束结构随环境pH值转变过程中聚氨基酸链段二级结构的变化.以阿霉素作为模型药物,研究了三嵌段共聚物的载药能力和在不同pH条件下的药物释放能力.在碱性条件下,PLGA链段去质子化,链段从疏水性变为亲水性,胶束中间层由于水合作用变得松散,药物释放速率增加;在酸性条件下,PLGA链段质子化,不带电荷,与阿霉素药物分子间的静电相互作用消失.同时,PLGA链段α-螺旋含量增加,形成由链内氢键维持的刚性棒状结构,将链段周围包埋的药物分子"挤出",加速了药物的释放.     

聚L-丙氨酸-聚乙二醇嵌段共聚物的胶束化行为研究

以氨基聚乙二醇单甲醚(MPEG-NH₂)为大分子引发剂, 采用开环聚合方法合成了聚L-丙氨酸-聚乙二醇嵌段共聚物(PAME), 并对其结构进行了表征; 用圆二色谱(CD)研究了嵌段共聚物在水溶液中的二级结构, 用芘荧光探针技术研究了共聚物胶束的形成及其临界胶束浓度(CMC), 利用动态光散射(DLS)和透射电镜(TEM)研究了胶束的粒径分布和形态. 结果表明, 在水溶液中共聚物链以α-螺旋构象形式存在, 在一定条件下嵌段共聚物能够形成球形的稳定胶束, PAME-1形成胶束的CMC为1.99×10^-5 mol/L, CMC值受共聚物中聚L-丙氨酸(PLA)链段含量的影响.     

AB型聚乙二醇单甲醚-聚(L-丙氨酸)嵌段共聚物自组装过程的核磁共振研究

利用核磁共振方法研究了AB型双嵌段共聚物(MPEG45-b-PA32)在选择性溶剂中的自组装行为及胶束化过程.嵌段共聚物在三氟乙酸中聚氨基酸和聚乙二醇链段均处于自由运动状态,聚丙氨酸链段为无规线团结构.在向该溶液中逐渐加入氘代水的过程中,聚丙氨酸链段又重新聚集形成规整的二级结构.结合1H-NMR和COSY谱分析,结果显示这一自组装过程伴随着聚(L-丙氨酸)链段由无规线团向α-螺旋结构的构象转变,同时嵌段共聚物逐渐形成核-壳型胶束结构.利用透射电镜观察了所形成胶束的形态,嵌段共聚物主要形成粒径150 nm到220 nm的球形胶束.     

ABA型聚L-丙氨酸-聚乙二醇嵌段共聚物的合成及其表征

利用L-α-丙氨酸和三聚光气反应制备了N-羧基-α-丙氨酸-环内酸酐(NCA).以聚乙二醇(PEG)为原料.制备了端氨基聚乙二醇(PEG-NH₂),并以此作为引发剂,引发NCA开环聚合.合成了不同组成和分子量的聚L-丙氨酸-聚乙二醇(PLAA-PEG-PLAA)嵌段共聚物.利用IR、¹H NMR、DSC、WAXD、CD等方法对共聚物结构进行了表征.结果表明,PEG-NH₂引发NCA开环聚合得到的是嵌段共聚物,通过¹H NMR谱得到共聚物组成及数均分子量;引入PEG的结果使聚L-丙氨酸的亲水性有所改善;CD测诚结果表明共聚物在水溶液中主链主要以α-螺旋构象存在.     

聚L-丙氨酸-聚乙二醇嵌段共聚物纳米胶束的研究

分别以氨基聚乙二醇和氨基聚乙二醇单甲醚为大分子引发剂,采用开环聚合的方法合成了两亲性聚L-丙氨酸-聚乙二醇(PAE)和聚L-丙氨酸-聚乙二醇单甲醚(PAME)两种嵌段共聚物,其结构经1H NMR,IR,DSC,GPC等表征;利用园二色技术研究了其在水溶液中的二级结构,用芘荧光探针技术研究了其胶束的形成及其临界胶束浓度(CMC),利用透射电镜研究了胶束的形态。结果表明,在水溶液中共聚物链以α-螺旋构象形式存在,在一定条件下嵌段共聚物PAE-1,PAE-2,PAME-1和PAME-2能够形成球形的稳定胶束,PAE-1形成胶束的CMC为3.36×10-5mol.L-1,CMC值受嵌段类型和共聚物中聚L-丙氨酸链段含量的影响。     

用固体高分辨NMR研究聚(L-丙氨酸)-聚乙二醇单甲醚双嵌段共聚物的微相结构与链段运动

利用固体高分辨¹³CCP/MAS及二维WISE核磁共振技术研究了聚(L-丙氨酸)-聚乙二醇单甲醚双嵌段共聚物(MPEG-b-PLA)在固态下的微相结构和链段运动行为.结果表明,聚乙二醇链段在形成嵌段共聚物后结晶度明显下降,同时存在晶区和非晶区,从而表现出两种不同的运动状态.而聚乙二醇链段的引入对聚L-丙氨酸链段影响不大,嵌段共聚物中聚L-丙氨酸链段高度结晶,同时含有大量的α螺旋结构,分子链运动严重受限,估计聚L-丙氨酸链段的相区尺寸很小.     

温度/pH响应性MPEG-b-PCL/PNVCL-b-PCL共聚物复合胶束的制备及载药性质

以基于亚胺键的嵌段共聚物为构筑单元的温度/pH响应性共聚物复合胶束(CMs), 由于具有亚胺键和核-壳-冠结构, 表现出较高的灵敏度和稳定性. 以聚乙二醇单甲醚(MPEG)、 N-乙烯基己内酰胺(NVCL)和ε-己内酯(ε-CL)为原料, 分别制备了端醛基聚乙二醇单甲醚(MPEG-CHO)、 端醛基聚N-乙烯基己内酰胺(PNVCL-CHO)和端氨基聚己内酯(H₂N-PCL), 利用希夫碱反应, 进一步制备了基于亚胺键的聚乙二醇单甲醚-b-聚己内酯(MPEG-b-PCL)和聚N-乙烯基己内酰胺-b-聚己内酯(PNVCL-b-PCL)嵌段共聚物, 对共聚物结构进行了确认. 以MPEG-b-PCL和PNVCL-b-PCL为构筑单元, 制备了共聚物复合胶束, 研究了复合胶束对阿霉素的包载、 释放性质和细胞毒性等. 研究结果表明, 室温下MPEG-b-PCL和PNVCL-b-PCL能够在水中自组装形成以PCL为核、 MPEG和PNVCL为混合壳的共聚物复合胶束, 在生理温度下, 温敏性PNVCL链段发生相变塌缩在PCL核表面, 能够防止药物扩散释放, 亲水性MPEG链段形成可控通道. 药物体外释放结果表明, 在弱酸性环境中, 亚胺键能够断裂, 胶束被破坏, 促进药物的释放, 噻唑蓝(MTT)实验表明, 复合胶束的细胞毒性较低.     

聚环氧乙烷-g-聚己内酯两亲性接枝共聚物的合成及药物释放行为

通过环氧丙醇(GL)与环氧乙烷(EO)的阴离子顺序开环聚合制备了水溶性嵌段共聚物PEO-b-PGL, 以PGL嵌段每个重复单元的侧羟基为引发点进一步引发ε-己内酯(CL)的开环聚合, 合成了结构规整的以聚环氧乙烷(PEO)为主链的两亲性接枝共聚物(PEO-b-PGL-g-PCL). 研究了PEO-b-PGL-g-PCL在水相中的自组装行为, 采用稳态荧光探针法测定了胶束的临界胶束浓度(cmc). 以疏水性药物阿霉素(DOX)为模型药物, 研究了两亲性接枝共聚物的化学组成对药物的扩散释放以及降解释放行为的影响.     

苯胺四聚体-聚乙二醇-苯胺四聚体嵌段共聚物薄膜的自组装

以氨基封端的苯胺四聚体为基础,以甲苯2,4-二异氰酸酯(TDI)为中间体制备了苯胺四聚体-聚乙二醇-苯胺四聚体(ANI₄-PEG-ANI₄,PEG600,M_n＝600)嵌段共聚物,并溶于乙醇/N,N-二甲基甲酰胺(DMF)混合溶剂后,涂覆于导电玻璃(ITO)表面制备成薄膜,利用原子力显微镜(AFM)、紫外-可见光谱(UV-Vis)和循环伏安(CV)等研究了薄膜的自组装及电化学行为等,讨论了诱导溶剂对嵌段共聚物薄膜形态和性能的影响. 研究发现,通过改变混合溶剂比和诱导溶剂种类,ANI₄-PEG-ANI₄嵌段共聚物薄膜可以实现多种形态的转变.     

Self‐assembly of thermo‐ and pH‐responsive poly(acrylic acid)‐b‐poly(N‐isopropylacrylamide) micelles for drug delivery

Self‐assembled thermo‐ and pH‐responsive poly(acrylic acid)‐b‐poly(N‐isopropylacrylamide) (PAA‐b‐PNIPAM) micelles for entrapment and release of doxorubicin (DOX) was described. Block copolymer PAA‐b‐PNIPAM associated into core‐shell micelles in aqueous solution with collapsed PNIPAM block or protonated PAA block as the core on changing temperature or pH. Complexation of DOX with PAA‐b‐PNIPAM triggered by the electrostatic interaction and release of DOX from the complexes due to the changing of pH or temperature were studied. Complex micelles incorporated with DOX exhibited pH‐responsive and thermoresponsive drug release profile. The release of DOX from micelles was suppressed at pH 7.2 and accelerated at pH 4.0 due to the protonation of carboxyl groups. Furthermore, the cumulative release of DOX from complex micelles was enhanced around LCST ascribed to the structure deformation of the micelles. © 2008 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 46: 5028–5035, 2008     

Synthesis of poly(acrylic acid) (PAA) modified Pluronic P123 copolymers for pH-stimulated release of doxorubicin

Pluronic P123 was chain-extended at their terminal groups using atom transfer radical polymerization to form poly(acrylic acid) (PAA) tails and obtain the PAA-b-P123-b-PAA (P123-PAA) copolymer. The incorporation of PAA had the effect of increasing the carrier's drug loading capacity of an anti-cancer drug, Doxorubicin (DOX), and also allowed for pH-controlled release of the drug. Drug release assays showed that up to 60% of DOX cargo could be retained in the DOX/P123-PAA complex for 3 days at normal physiological pH (7.4). This was then followed by a secondary burst release of DOX when the environment became more acidic (pH 5). Therefore, it was possible that the more acidic physiological environment of tumor sites could be used to trigger an accelerated release of DOX from the drug carriers. The material was demonstrated for potential application in the delivery of cationic drugs for cancer treatment.     

Amphiphilic linear-dendritic triblock copolymers composed of poly(amidoamine) and poly(propylene oxide) and their micellar-phase and encapsulation properties

A novel amphiphilic ABA dendritic-linear-dendritic block copolymer consisting of poly(amidoamine) and poly(propylene oxide) has been synthesized. The solution-phase behavior of the block copolymer was studied as a function of the generation of the dendritic block, ionic strength, and solution pH. The triblock self-assembles in aqueous media to form stable micelles with CMC values ranging from 10(-6) to 10(-5) M. Dynamic light scattering results indicate the formation of particles ranging from 9 to 18 nm in diameter, with smaller diameters exhibited at higher generations. Additional experiments were performed to assess the feasibility of the nanoparticles for drug delivery applications. Drug loading studies were performed with a model hydrophobic drug, triclosan, resulting in high loading efficiencies ranging from 79 to 86%w/w. The dendritic-linear-dendritic block copolymer synthesized was found to be a promising candidate for drug delivery due to its relative stability in aqueous solution and its drug encapsulation and release properties.     

Synthesis and aggregation behavior of pluronic F87/poly(acrylic acid) block copolymer in the presence of doxorubicin

Poly(acrylic acid) (PAA) was polymerized on both termini of Pluronic F87 copolymer using the atom transfer radical polymerization technique to produce a novel block copolymer, PAA-b-F87-b-PAA (F87PAA). The loading of a cationic anticancer drug, doxorubicin (DOX), to F87PAA at different pH values was investigated using isothermal titration calorimetry (ITC), laser light scattering techniques, and UV-vis spectroscopy. At pH of 4.3-7.1, the ITC profile exhibited a significant exothermic peak, which indicated that the drug loading is an enthalpically driven process. At a pH of 4.3, the enthalpy maximum was significantly reduced in the presence of 2 M urea, indicating the existence of hydrogen bonds between the DOX and F87PAA copolymer. At a pH of 7.1, the fraction of bound DOX was close to the stoichiometric proportion of 1:1 to the molar concentration of carboxyl groups in the copolymer, where the drug loading is governed by electrostatic and stacking interactions. The TEM image of the complex indicated the formation of large compound micelles induced by the binding of DOX to the PAA segments.     

Hydrogen Peroxide and Glutathione Dual Redox‐Responsive Nanoparticles for Controlled DOX Release

Polymer nanoparticulate drug delivery systems that respond to reactive oxygen species (ROS) and glutathione (GSH) simultaneously at biologically relevant levels hold great promise to improve the therapeutic efficacy to cancer cells with reduced side effects of chemo drugs. Herein, a novel redox dual‐responsive amphiphilic block copolymer (ABP) that consists of a hydrophilic poly (ethylene oxide) block and a hydrophobic block bearing disulfide linked phenylboronic ester group as pendant is synthesized, and the DOX loaded nanoparticles (BSN‐DOX) based on ABPs with varied hydrophobic block length are fabricated for DOX delivery. The self‐immolative leaving reaction of phenylboronic ester triggered by extracellular ROS and the cleavage of disulfide linkages induced by intracellular GSH both lead to rapid DOX release from BSN‐DOX, resulting in an on‐demand DOX release. Moreover, BSN‐DOX show better tumor inhibition and lower side effects in vivo compared with free drug.     

以磁纳米粒为核的pH敏感型聚谷氨酸树状分子药物载体

报道了一种新的肽类树枝状分子改性磁性纳米药物载体.以天然氨基酸L-谷氨酸为原料,通过收敛法合成了聚(L-谷氨酸)树状分子,将多巴胺配体键合到聚(L-谷氨酸)树状分子上,用核磁(1H-NMR)、质谱(MS)对合成出的树状分子配体进行了表征,然后通过配体交换对四氧化三铁磁纳米粒表面进行多功能化.以阿霉素为模型药物通过pH敏...     

Degradable dual pH- and temperature-responsive photoluminescent dendrimers

Poly(β-aminoester) dendrimers have been prepared. These systems represent the first degradable dual pH- and temperature-responsive dendrimers displaying photoluminescence. The pH/temperature sensitivities are interrelated; the lower critical solution temperature of the dendrimer decreases as the pH of the solution is increased. The sensitivities are mainly due to phase changes of the surface groups with changes in pH or temperature. These dual-responsive dendrimers are very useful in drug delivery. They may be loaded with a hydrophobic drug at low temperature without using organic solvents. The loaded drug is released very slowly and steadily at 37 °C and physiological pH, but can be quickly released at acidic pH, for example the lysosomal pH (pH 4-5), for intracellular drug release. These dendrimers also display strong photoluminescence, which can be exploited for monitoring drug loading and release. Thus, poly(β-aminoester) dendrimers constitute ideal drug carriers since their thermal sensitivity allows the loading of drugs without using organic solvents, their pH sensitivity permits fast intracellular drug release, and their photoluminescence provides a means of monitoring drug loading and release.     

pH-Responsive Self-assembled Nanoparticles of Simulated P(AA-co-SA)-g-PEG for Drug Release

Simulated graft copolymer of poly(acrylic acid-co-stearyl acylate) [P(AA-co-SA)] and poly(ethylene glycol) (PEG) was synthesized, where acrylic acid, stearyl acylate and PEG was employed as the pH-sensitive, hydrophobic and hydrophilic segment, respectively. Polymeric nanoparticles prepared by the dialysis of simulated graft copolymer solution in dimethylformamide against citrate buffer solution with different pH values were characterized by transmission electron microscopy (TEM), fluorescence technique and laser light scattering (LLS). TEM image revealed the spherical shape of the self-aggregates, which was further confirmed by LLS measurements. The critical aggregation concentration increased markedly (10 to 150 mg/L) with increasing pH (4.6 to 7.0), consistent with the de-protonation of carboxylic groups at higher pH. The hydrodynamic radius of polymeric nanoparticles decreased from 118 nm at pH 3.4 to 90 nm at pH 7.0. The controlled release of indomethacin from those nanoparticles was investigated, and the self-assembled nanoparticles exhibited improved performance in controlled drug release.